INSM Q2 2019 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$30B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$30M

Gross Profit

$25M83.6% margin

Operating Income

-$62M-207.4% margin

Net Income

-$67M-221.9% margin

EPS (Diluted)

$-0.81

QoQ Revenue Growth

+36.8%

Cash Flow

Operating Cash Flow

-$80M

Free Cash Flow

-$91M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$803M

Total Liabilities

$446M

Stockholders' Equity

$357M

Cash & Equivalents

$601M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$0	—
Gross Profit	$25M	$0	—
Operating Income	-$62M	-$73M	+14.7%
Net Income	-$67M	-$76M	+13.0%